CLASS II ONGOING Device recall · Reported 17 May 2023 · FDA Enforcement Report

BioPlex 2200 REF 665-2050, Apls IgM Pack, Apls IgM Reagent Pack recalled

Bio-Rad Laboratories is recalling BioPlex 2200 REF 665-2050, Apls IgM Pack, Apls IgM Reagent Pack, distributed nationwide in the US. The recall was initiated on 28 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: 301538; UDI-DI: (00)847865000666
Quantity recalled932 Reagent Packs

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1572-2023
FDA event ID
91889
Recalling firm
Bio-Rad Laboratories, Redmond, WA
Classification
Class II
Status
Ongoing
Recall initiated
28 Feb 2023
FDA classified
10 May 2023
Reported
17 May 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

28 Feb 2023Recall initiated by company
10 May 2023Classified by FDA+71 days
17 May 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

APLS IgM reagent kits were packaged with the incorrect conjugate, which could lead to an increase in false-positive and false-negative results.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

BioPlex 2200 REF 665-2050, APLS IgM Pack, APLS IgM Reagent Pack

Where it was distributed

US Nationwide distribution including in the states of AL, AR, AZ, CA, CT, FL, HI, IL, IN, KS, KY, LA, MI, MO, NC, ND, NE, NJ, NM, NY, OH, OK, PR,SC, TN, TX, UT, VT.

Nationwide AlabamaArkansasArizonaCaliforniaConnecticutFloridaHawaiiIllinoisIndianaKansasKentuckyLouisianaMichiganMissouriNorth CarolinaNorth DakotaNebraskaNew JerseyNew MexicoNew York

Questions about this recall

Why was it recalled?

APLS IgM reagent kits were packaged with the incorrect conjugate, which could lead to an increase in false-positive and false-negative results.

Which lots are affected?

Lot Code: 301538; UDI-DI: (00)847865000666

Where was it sold?

US Nationwide distribution including in the states of AL, AR, AZ, CA, CT, FL, HI, IL, IN, KS, KY, LA, MI, MO, NC, ND, NE, NJ, NM, NY, OH, OK, PR,SC, TN, TX, UT, VT.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bio-Rad Laboratories

All 27

Other Test Kits & Diagnostics recalls

All 2,661